🚀 ProPicks AI Hits +34.9% Return!Read Now

Why Is GameStop Surging By Around 10%? 22 Stocks Moving In Thursday's Pre-Market Session

Published 07/07/2022, 11:25
Updated 07/07/2022, 12:10
© Reuters Why Is GameStop Surging By Around 10%? 22 Stocks Moving In Thursday's Pre-Market Session
GME
-
IXIC
-

Gainers

  • Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 39.6% to $0.2471 in pre-market trading after declining over 8% on Wednesday. Allena Pharmaceuticals recently announced rescheduling of special meeting to approve reverse stock split.
  • United Maritime Corporation (NASDAQ: USEA) rose 33.2% to $3.81 in pre-market trading. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp.
  • AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) rose 27.4% to $0.3301 in pre-market trading after gaining around 4% on Wednesday.
  • Cryptyde, Inc. (NASDAQ: TYDE) rose 16.5% to $1.41 in pre-market trading. Cryptyde recently disclosed a corporate roadmap for the remainder of 2022 into 2023.
  • Dave Inc. (NASDAQ: DAVE) rose 16% to $0.84 in pre-market trading.
  • Veru Inc. (NASDAQ: VERU) rose 14.6% to $14.93 in pre-market trading. Veru shares gained 13% on Wednesday after the company announced the publication of the results from a Phase 3 COVID-19 study evaluating the efficacy and safety of oral sabizabulin for the treatment of hospitalized moderate-severe COVID-19 patients at high risk for ARDS and death in The New England Journal of Medicine Evidence.
  • Exicure, Inc. (NASDAQ: XCUR) rose 13.9% to $2.29 in pre-market trading.
  • Art's-Way Manufacturing Co., Inc. (NASDAQ: ARTW) rose 12.6% to $2.68 in pre-market trading. Art's-Way Manufacturing recently posted Q2 EPS of $0.04.
  • ZW Data Action Technologies Inc. (NASDAQ: CNET) rose 12.3% to $0.5399 in pre-market trading. ZW Data Action Tech, during May, reported a Q1 loss of $0.02 per share.
  • MIND Technology, Inc. (NASDAQ: MIND) rose 11.2% to $0.9273 in pre-market trading after the company announced that it received orders for sonar and source controller systems totaling approximately $7.7 million.
  • Connect Biopharma Holdings Limited (NASDAQ: CNTB) shares rose 9.7% to $0.9690 in pre-market trading.
  • Quotient Limited (NASDAQ: QTNT) rose 9.6% to $0.2730 in pre-market trading. Quotient Form4 filing showed that Director Zubeen Shroff reported purchase of 4.66 million shares at $0.30 pe share.
  • GameStop Corp . (NYSE: NYSE:GME) rose 9.6% to $128.70 in pre-market trading after the company announced a stock split.
  • Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 9% to $4.87 in pre-market trading after several SEC filings showed recent insider buying.
  • Caterpillar Inc. (NYSE: NYSE:CAT) rose 3.3% to $178.00 in pre-market trading.
Don’t forget to check out our premarket coverage here .

Losers

  • DiaMedica Therapeutics Inc. (NASDAQ: DMAC) fell 32.2% to $1.37 in pre-market trading after the company announced a clinical hold of its Phase 2/3 ReMEDy2 clinical trial for DM199.
  • CytomX Therapeutics, Inc. (NASDAQ: CTMX) fell 18% to $1.61 in pre-market trading after the company reported Phase 2 results for praluzatamab ravtansine in breast cancer. Piper Sandler and Mizuho downgraded the stock also.
  • Enjoy Technology, Inc. (NASDAQ: ENJY) shares fell 11.2% to $0.3720 in pre-market trading after jumping 35% on Wednesday.
  • Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) fell 11.1% to $0.7999 in pre-market trading. Titan Pharmaceuticals shares jumped 49% on Wednesday after the company announced FDA clearance of its IND application for nalmefene implant.
  • Revelation Biosciences, Inc. (NASDAQ: REVB) fell 9.2% to $1.09 in pre-market trading after jumping 44% on Wednesday.
  • Waitr Holdings Inc. (NASDAQ: WTRH) shares fell 8.1% to $0.2440 in pre-market trading after jumping 73% on Wednesday.
  • The Duckhorn Portfolio, Inc. (NASDAQ: NAPA) fell 6.3% to $19.42 in pre-market trading after the company reported a secondary offering of 5,000,000 shares of common stock.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.